125 related articles for article (PubMed ID: 3923141)
41. A plasminogen activator from benign ovarian cystadenoma: partial purification and characterization.
Cheung A; Lau HK; Yuen P
Thromb Res; 1986 Mar; 41(5):717-29. PubMed ID: 3961743
[TBL] [Abstract][Full Text] [Related]
42. Purification and characterization of a novel inhibitor of urokinase from human urine. Quantitation and preliminary characterization in plasma.
Stump DC; Thienpont M; Collen D
J Biol Chem; 1986 Sep; 261(27):12759-66. PubMed ID: 3091604
[TBL] [Abstract][Full Text] [Related]
43. Purification and characterization of human kidney plasminogen activator dissimilar to urokinase.
Sueishi K; Nanno S; Okamura T; Inoue S; Tanaka K
Biochim Biophys Acta; 1982 Aug; 717(2):327-36. PubMed ID: 7052141
[TBL] [Abstract][Full Text] [Related]
44. Purification of plasminogen activators from human seminal plasma.
Propping D; Zaneveld LJ; Tauber PF; Schumacher GF
Biochem J; 1978 May; 171(2):435-44. PubMed ID: 26336
[TBL] [Abstract][Full Text] [Related]
45. Urokinase-type plasminogen activator in ascites obtained from the patient with mammary cancer.
Hayashi S; Yamada K
Thromb Res; 1985 Jun; 38(5):459-67. PubMed ID: 4040279
[TBL] [Abstract][Full Text] [Related]
46. Characterization of a macrophage-derived plasminogen-activator inhibitor. Similarities with placental urokinase inhibitor.
Chapman HA; Stone OL
Biochem J; 1985 Aug; 230(1):109-16. PubMed ID: 2932100
[TBL] [Abstract][Full Text] [Related]
47. Purification of human tissue plasminogen activator with Erythrina trypsin inhibitor.
Heussen C; Joubert F; Dowdle EB
J Biol Chem; 1984 Oct; 259(19):11635-8. PubMed ID: 6541221
[TBL] [Abstract][Full Text] [Related]
48. Large-scale purification of human tissue-type plasminogen activator using monoclonal antibodies.
Einarsson M; Brandt J; Kaplan L
Biochim Biophys Acta; 1985 Jul; 830(1):1-10. PubMed ID: 4040396
[TBL] [Abstract][Full Text] [Related]
49. Fibrin binding, fibrinolytic and fibrinogenolytic activity of plasminogen activator derived from the paranasal mucous membrane of humans.
Yamashiro Y; Nakamura M; Huang GW; Kosugi T
Laryngoscope; 1993 Feb; 103(2):197-202. PubMed ID: 8426513
[TBL] [Abstract][Full Text] [Related]
50. Isolation and characterization of plasminogen activators from hyperplastic and malignant prostate tissue.
Kirchheimer J; Köller A; Binder BR
Biochim Biophys Acta; 1984 Feb; 797(2):256-65. PubMed ID: 6199043
[TBL] [Abstract][Full Text] [Related]
51. Rapid purification of a high-affinity plasminogen activator from human blood plasma by specific adsorption on fibrin/Celite.
Husain SS; Lipinski B; Greuwich V
Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4265-9. PubMed ID: 6270665
[TBL] [Abstract][Full Text] [Related]
52. Purification and partial characterization of plasminogen activator from human uterine tissue.
Rijken DC; Wijngaards G; Zaal-de Jong M; Welbergen J
Biochim Biophys Acta; 1979 Sep; 580(1):140-53. PubMed ID: 121055
[TBL] [Abstract][Full Text] [Related]
53. Isolation of plasminogen activator inhibitor-2 (PAI-2) from human placenta. Evidence for vitronectin/PAI-2 complexes in human placenta extract.
Radtke KP; Wenz KH; Heimburger N
Biol Chem Hoppe Seyler; 1990 Dec; 371(12):1119-27. PubMed ID: 1708670
[TBL] [Abstract][Full Text] [Related]
54. Purification and characterization of human vascular plasminogen activator.
Aasted B
Biochim Biophys Acta; 1980 Feb; 621(2):241-54. PubMed ID: 7188733
[TBL] [Abstract][Full Text] [Related]
55. Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin.
Clemmensen I; Petersen LC; Kluft C
Eur J Biochem; 1986 Apr; 156(2):327-33. PubMed ID: 3009181
[TBL] [Abstract][Full Text] [Related]
56. New type of plasminogen activator produced by an established cell line from human ovary.
Matsuo O; Fukao H; Matsuo C; Ueshima S
Thromb Res Suppl; 1988; 8():45-55. PubMed ID: 3144768
[TBL] [Abstract][Full Text] [Related]
57. Isolation from human plasma of a plasminogen activator identical to urinary high molecular weight urokinase.
Tissot JD; Schneider P; Hauert J; Ruegg M; Kruithof EK; Bachmann F
J Clin Invest; 1982 Dec; 70(6):1320-3. PubMed ID: 6757269
[TBL] [Abstract][Full Text] [Related]
58. Purification and properties of a plasminogen activator from pig heart.
Cole ER; Bachmann FW
J Biol Chem; 1977 Jun; 252(11):3729-37. PubMed ID: 863901
[TBL] [Abstract][Full Text] [Related]
59. [The antithrombotic and thrombolytic activity of a plasminogen activator isolated from a monolayer cell culture].
Liapina LA; Pastorova VE; Koval'chuk GA; Leĭkina MI; Leĭkina GA; Poliakova IA
Izv Akad Nauk Ser Biol; 1994; (3):468-71. PubMed ID: 7858466
[TBL] [Abstract][Full Text] [Related]
60. Characterization of plasminogen activators from normal human breast and colon and from breast and colon carcinomas.
Tissot JD; Hauert J; Bachmann F
Int J Cancer; 1984 Sep; 34(3):295-302. PubMed ID: 6237065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
